Skip to main content
Premium Trial:

Request an Annual Quote

NetGenics Snags Avalon as its Third DiscoveryCenter Customer


NetGenics has signed on Avalon Pharmaceuticals as the third customer for its recently launched DiscoveryCenter integration platform. Avalon joins Paradigm Genetics, which licensed the software in early October, and Schering AG, which is building a corporate-wide gene database using DiscoveryCenter components.

NetGenics recently completed the second stage of implementing the database at Schering, a project that began in June. Michael Bush, director of sales at NetGenics, said that over 100 Schering researchers in Germany and the US now have access to the same data sources through the system.

The implementation “has gone off without a hitch,” Bush said, adding that some researchers have already used the system to find similar projects within the organization and have begun to pool their resources, eliminating duplicated efforts.

Bush said that the Avalon and Paradigm installations are smaller than the Schering deployment. Around 10 people will use the system at Avalon, he said, with the option to add more users as necessary.

The Paradigm installation will begin this week.

The core software behind DiscoveryCenter is similar for every customer, Bush said, but different modules and data sources are added to meet the unique needs of an organization. In addition, the platform’s open API allows users to extend the system as needed.


Filed under

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.